We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Improved Stroke Outcome at 6 Months

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: July 22, 2005
Last Update Posted: June 27, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
RehaClinic Zurzach
Information provided by:
Kantonsspital Baden
The investigators implemented a structured chain of acute stroke care with early integrated rehabilitation. The mortality at 6 months was lower (12%) compared to 23% in the International Stroke Trial (IST) and 39% (67%) of the patients were dead or dependent, which is superior compared to international data.

Condition Intervention Phase
Stroke Procedure: Stroke treatment Phase 4

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Improved Stroke Outcome at 6 Months Attained by a Chain of Structured Acute Treatment With Integrated Rehabilitation and Supported Discharge

Resource links provided by NLM:

Further study details as provided by Kantonsspital Baden:

Estimated Enrollment: 200
Study Start Date: January 2002
Estimated Study Completion Date: January 2005
Detailed Description:

Background/Aim of the study: To further reduce the 6 months stroke morbidity and mortality in a high volume stroke hospital and to compare the results with national and international data.

Methods: 204 consecutive stroke patients are analyzed in a prospective study in a single center teaching institution. The intervention consists of a structured therapeutic chain of 290 collaborating GPs, a standardised acute hospital proceeding overlapping with an early integrated neurovascular rehabilitation within the same institution. Primary endpoints include death and dependence at 6 months, secondary endpoints are the length of hospital stay (LOS) and the quantitative analysis of physical and psychosocial impairments. The data are directly compared with the same endpoints of the Swiss subgroup of the international stroke trial (IST) and recent international data.

Results: At 6 months, mortality is significantly lower with 12 % (compared to 23 % in the IST trial) and only 39 % (67 %) of the patients are dead or dependent. Stroke severity is similar as in other study populations. Median LOS is 15 days in the acute clinic and 39 days in the rehabilitation institution. The psychosocial outcome compares favorably to a matched control group.

Conclusions: A structured chain of acute stroke treatment overlapping with an early integrated rehabilitation is superior compared to national and international ischemic stroke trial data.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • An acute cerebrovascular event (ischemic stroke or intra-cerebral bleeding (ICB)) with the signs and symptoms of an acute stroke according to the World Health Organisation definition of acute stroke within the last 12 hours without the need or possibility of a neurosurgical intervention;
  • No thrombolytic therapy within the first 3 hours (in order to allow the correct comparison with the Swiss cohort of the IST trial)
  • The informed consent of the patient or, if not possible, of the next of kindred
  • Living at home before the event
  • Lack of participation in another trial

Exclusion Criteria:

  • Transient ischemic attack (TIA) resp. full recovery within 24 hours after the event
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00122798

Kantonsspital Baden
Baden, Aargau, Switzerland, 5404
Sponsors and Collaborators
Kantonsspital Baden
RehaClinic Zurzach
Principal Investigator: Juerg H Beer, M.D Dept of Medicine, Kantonsspital Baden, Switzerland
  More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00122798     History of Changes
Other Study ID Numbers: EK 50
First Submitted: July 21, 2005
First Posted: July 22, 2005
Last Update Posted: June 27, 2006
Last Verified: December 2004

Keywords provided by Kantonsspital Baden:
Stroke, stroke treatment, atrial fibrillation, medication, rehabilitation

Additional relevant MeSH terms:
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases